| Postoperative pancreatic fistula: an international study group (ISGPF) definition C Bassi, C Dervenis, G Butturini, A Fingerhut, C Yeo, J Izbicki, ... Surgery 138 (1), 8-13, 2005 | 5179 | 2005 |
| A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992 EL Bradley Archives of surgery 128 (5), 586-590, 1993 | 4584 | 1993 |
| A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer JP Neoptolemos, DD Stocken, H Friess, C Bassi, JA Dunn, H Hickey, ... New England Journal of Medicine 350 (12), 1200-1210, 2004 | 3295 | 2004 |
| The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after C Bassi, G Marchegiani, C Dervenis, M Sarr, MA Hilal, M Adham, P Allen, ... Surgery 161 (3), 584-591, 2017 | 3146 | 2017 |
| Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS) MN Wente, C Bassi, C Dervenis, A Fingerhut, DJ Gouma, JR Izbicki, ... Surgery 142 (5), 761-768, 2007 | 2880 | 2007 |
| Postpancreatectomy hemorrhage (PPH)–an international study group of pancreatic surgery (ISGPS) definition MN Wente, JA Veit, C Bassi, C Dervenis, A Fingerhut, DJ Gouma, ... surgery 142 (1), 20-25, 2007 | 2467 | 2007 |
| Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised … JP Neoptolemos, DH Palmer, P Ghaneh, EE Psarelli, JW Valle, ... The Lancet 389 (10073), 1011-1024, 2017 | 1853 | 2017 |
| Pancreatic cancer J Kleeff, M Korc, M Apte, C La Vecchia, CD Johnson, AV Biankin, ... Nature reviews Disease primers 2 (1), 1-22, 2016 | 1830 | 2016 |
| Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial JP Neoptolemos, DD Stocken, C Bassi, P Ghaneh, D Cunningham, ... Jama 304 (10), 1073-1081, 2010 | 1616 | 2010 |
| IAP guidelines for the surgical management of acute pancreatitis W Uhl, A Warshaw, C Imrie, C Bassi, CJ McKay, PG Lankisch, R Carter, ... Pancreatology 2 (6), 565-573, 2002 | 1466 | 2002 |
| Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial JP Neoptolemos, JA Dunn, DD Stocken, J Almond, K Link, H Beger, ... The Lancet 358 (9293), 1576-1585, 2001 | 1348 | 2001 |
| Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones JP Neoptolemos, NJ London, D James, DL Carr-Locke, IA Bailey, ... The Lancet 332 (8618), 979-983, 1988 | 1227 | 1988 |
| Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer D Cunningham, I Chau, DD Stocken, JW Valle, D Smith, W Steward, ... Journal of Clinical Oncology 27 (33), 5513-5518, 2009 | 975 | 2009 |
| Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study JN Primrose, RP Fox, DH Palmer, HZ Malik, R Prasad, D Mirza, A Anthony, ... The Lancet Oncology 20 (5), 663-673, 2019 | 959 | 2019 |
| Therapeutic developments in pancreatic cancer: current and future perspectives JP Neoptolemos, J Kleeff, P Michl, E Costello, W Greenhalf, DH Palmer Nature reviews Gastroenterology & hepatology 15 (6), 333-348, 2018 | 919 | 2018 |
| Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS) M Bockhorn, FG Uzunoglu, M Adham, C Imrie, M Milicevic, AA Sandberg, ... Surgery 155 (6), 977-988, 2014 | 863 | 2014 |
| Inflammatory mediators in acute pancreatitis M Bhatia, M Brady, S Shokuhi, S Christmas, JP Neoptolemos, J Slavin The Journal of Pathology: A Journal of the Pathological Society of Great …, 2000 | 859 | 2000 |
| Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial JP Neoptolemos, DD Stocken, JA Dunn, J Almond, HG Beger, P Pederzoli, ... Annals of surgery 234 (6), 758-768, 2001 | 721 | 2001 |
| Optimizing the outcomes of pancreatic cancer surgery O Strobel, J Neoptolemos, D Jaeger, MW Buechler Nature reviews Clinical oncology 16 (1), 11-26, 2019 | 667 | 2019 |
| Clinical and genetic characteristics of hereditary pancreatitis in Europe N Howes, MM Lerch, W Greenhalf, DD Stocken, I Ellis, P Simon, ... Clinical Gastroenterology and Hepatology 2 (3), 252-261, 2004 | 665 | 2004 |
Claudio BassiProfessore di Chirurgia Pancreatica, Università di VeronaVerified email at univr.it
